In This Article:
Cheng Xin / Getty Images
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates.
The medical device maker reported adjusted earnings per share (EPS) of $1.45 on revenue of $5.32 billion. Analysts polled by Visible Alpha expected $1.26 and $5.32 billion, respectively.
GE HealthCare shares, which entered the day up about 3% over the last 12 months, were little changed immediately following the report.
The company said it expects year-over-year organic revenue growth of 2% to 3% in 2025, "which reflects continued demand for our products and services as well as a measured view of market conditions in China." GE HealthCare also projected adjusted EPS between $4.61 and $4.75, up 3% to 6% from the $4.49 it registered in 2024 and mostly above the $4.65 analyst consensus.
Last quarter, the former division of conglomerate General Electric topped profit estimates despite what it called "continued market softness" in China, which led GE HealthCare to say it was trending toward the lower end of its 1% to 2% full-year organic revenue growth projection. The firm's 2024 organic revenue came in a $19.74 billion, up 1%.
GE HealthCare's Q4 results follow those of the other two former GE segments, GE Aerospace (GE) and GE Vernova (GEV). Shares of both rose following their reports late last month.
Read the original article on Investopedia